The Promise of Cancer Immunotherapy

Marcela Maus, Massachusetts General Hospital Cancer Center

The Promise of Cancer Immunotherapy

Marcela Maus, Director of Cellular Immunotherapy, Massachusetts General Hospital Cancer Center

Marcela Maus is the director of cellular immunotherapy at the Massachusetts General Hospital Cancer Center, a member of the Center for Cancer Immunology and the Department of Medicine at MGH, and an assistant professor at Harvard Medical School. Her laboratory is generating new forms of chimeric antigen receptors directed to new targets and bringing them to the clinical setting to treat patients with hematologic malignancies and solid tumors. Maus trained in internal medicine at U. Penn and at Memorial Sloan Kettering as a hematologist and medical oncologist. In postdoctoral works with Michel Sadelain and Carl June, she designed early-phase trials of T-cell therapies for multiple myeloma, chronic lymphocytic leukemia, and glioblastoma.

Topics

Rewriting Life
Reprogramming our bodies to make us healthier.

Please enter your email address to view this free video.

We'd like to keep in touch about future MIT Technology Review initiatives and events.